Baradaran Sharyar 4
4 · NURX PHARMACEUTICALS, INC. · Filed Nov 4, 2009
Insider Transaction Report
Form 4
Baradaran Sharyar
Director
Transactions
- Purchase
Common Stock
2009-10-13$0.25/sh+200,000$50,000→ 1,225,000 total(indirect: By Trust) - Purchase
Common Stock
2009-09-23+900,000→ 1,025,000 total(indirect: By Trust) - Purchase
Common Stock Warrants (right to buy)
2009-09-23+1,383,750→ 1,383,750 total(indirect: By Trust)Exercise: $4.00From: 2009-09-23Exp: 2013-05-16→ Common Stock (1,383,750 underlying)
Footnotes (1)
- [F1]The reporting person acquired 900,000 shares and warrants to acquire 1,383,750 shares for an aggregate purchase price of $180,000.